Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer or With Stage I or Stage II Mesothelioma - Related Studies

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

This study is ongoing, but not recruiting participants.

Study NCT00003974. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lung Cancer
		Malignant Mesothelioma

2	Additional conditions recognized in this trial
		Carcinoma, Non-Small-Cell Lung
		Lung Neoplasms
		Mesothelioma

3	More general conditions related to this trial
		Adenoma
		Carcinoma
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Neoplasms, Mesothelial
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		DetoxPC
		cyclophosphamide
		lung tumor associated antigen
		chemotherapy

5	More general drug interventions related to this trial
		Alkylating Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antirheumatic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Roswell Park Cancer Institute
		National Cancer Institute (NCI)